Form 4 holding
SVP OF REGULATORY AFFAIRS
Celldex Therapeutics, Inc.
- Security class
- Incentive Stock Option (right to buy)
- Shares / value
- 82,000
- Estimated value
- Report date
- 05 Jun 2025
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount